Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore

被引:31
作者
Zhi, L [1 ]
Ringgenberg, JD [1 ]
Edwards, JP [1 ]
Tegley, CM [1 ]
West, SJ [1 ]
Pio, B [1 ]
Motamedi, M [1 ]
Jones, TK [1 ]
Marschke, KB [1 ]
Mais, DE [1 ]
Schrader, WT [1 ]
机构
[1] Ligand Pharmaceut Inc, Discovery Res, San Diego, CA 92121 USA
关键词
D O I
10.1016/S0960-894X(03)00256-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 1,2-dihydrochromeno[3,4-f]quinoline derivatives was synthesized and tested in biological assays to evaluate the nonsteroidal progesterone receptor modulator pharmacophore (4) as antiprogestins. A number of potent analogues were identified by modification of the substituents at the D-ring. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2075 / 2078
页数:4
相关论文
共 21 条
[1]   5-aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists:: The effect of D-ring substituents [J].
Edwards, JP ;
West, SJ ;
Marschke, KB ;
Mais, DE ;
Gottardis, MM ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) :303-310
[2]   Preparation, resolution, and biological evaluation of 5-aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines:: Potent, orally active, nonsteroidal progesterone receptor agonists [J].
Edwards, JP ;
Zhi, L ;
Pooley, CLF ;
Tegley, CM ;
West, SJ ;
Wang, MW ;
Gottardis, MM ;
Pathirana, C ;
Schrader, WT ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2779-2785
[4]   THE SYNTHESIS AND TRANSITION-TEMPERATURES OF SOME 4,4''-DIALKYL-1,1'-4',1''-TERPHENYL AND 4,4''-ALKOXYALKYL-1,1'-4',1''-TERPHENYL WITH 2,3-DIFLUORO OR 2',3'-DIFLUORO SUBSTITUENTS AND OF THEIR BIPHENYL ANALOGS [J].
GRAY, GW ;
HIRD, M ;
LACEY, D ;
TOYNE, KJ .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1989, (12) :2041-2053
[5]   Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines [J].
Hamann, LG ;
Winn, DT ;
Pooley, CLF ;
Tegley, CM ;
West, SJ ;
Farmer, LJ ;
Zhi, L ;
Edwards, JP ;
Marschke, KB ;
Mais, DE ;
Goldman, ME ;
Jones, TK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (19) :2731-2736
[6]   Preclinical experience with two selective progesterone receptor modulators on breast and endometrium [J].
Kloosterboer, HJ ;
Deckers, GH ;
Schoonen, WGEJ ;
Hanssen, RGJM ;
Rose, UM ;
Verbost, PM ;
Hsiu, JG ;
Williams, RF ;
Hodgen, GD .
STEROIDS, 2000, 65 (10-11) :733-740
[7]  
MCDONNELL DP, 1993, BIO-TECHNOL, V11, P1256
[8]   Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity [J].
Palmer, S ;
Campen, CA ;
Allan, GF ;
Rybczynski, P ;
Haynes-Johnson, D ;
Hutchins, A ;
Kraft, P ;
Kiddoe, M ;
Lai, MT ;
Lombardi, E ;
Pedersen, P ;
Hodgen, G ;
Combs, DW .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 75 (01) :33-42
[9]   Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore [J].
Pooley, CLF ;
Edwards, JP ;
Goldman, ME ;
Wang, MW ;
Marschke, KB ;
Crombie, DL ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3461-3466
[10]   INTRACELLULAR RECEPTORS AND SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION SUPERFAMILIES - NOVEL TARGETS FOR SMALL-MOLECULE DRUG DISCOVERY [J].
ROSEN, J ;
DAY, A ;
JONES, TK ;
JONES, ETT ;
NADZAN, AM ;
STEIN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4855-4874